0.21 USD
↘ 0.00 (1.83%)AT CLOSE (03:59 PM EST)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
0.21
↘ 0.01 (4.21%)
POST MARKET (AS OF 04:13 PM EST)
Post Market
AS OF 04:13 PM EST
0.21
↘ 0.01 (4.21%)
Market: CLOSED
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $0.21. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ABOS is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 13, 2026.
Open?$0.22
High?$0.23
Low?$0.19
Prev. Close?$0.22
Volume?2.8M
Avg. Volume?4.9M
VWAP?$0.21
Rel. Volume?0.57x
Bid / Ask
Bid?$0.20 × 1.8K
Ask?$0.21 × 100
Spread?$0.01
Midpoint?$0.21
Valuation & Ratios
Market Cap?15.9M
Shares Out?72.3M
Float?40.6M
Float %?56.2%
P/E Ratio?N/A
P/B Ratio?0.46
EPS?-$1.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
15.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.88Distress
Confidence?49%Low
Short InterestHigh
Short % of Float?11.22%High
Short Interest?4.6M
Days to Cover?1.0
Free Float40.6M
Avg Daily Volume6.9M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.89Adequate
Quick Ratio?1.89Adequate
Cash Ratio?1.18Strong
Debt/Equity?0.76Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.46CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.1CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-300.4%WEAK▾
S&P3
ROA?-121.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-87952000
Enterprise Value?$-10890990
Fundamentals ratios updated end of day